University of California, San Francisco
San Francisco, California, United States
141 recruiting
Showing 1–20 of 283 trials
Recruiting
Phase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Type 2 Diabetes
Eli Lilly and Company55 enrolled51 locationsNCT06739122
Recruiting
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
HIV InfectionsOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
University of California, San Francisco144 enrolled1 locationNCT06055868
Recruiting
Phase 1
Combination Therapy in Cancers With Mutations in DNA Repair Genes
Metastatic Solid TumorBRCA1 MutationBRCA2 Mutation+2 more
University of California, San Francisco24 enrolled1 locationNCT05694715
Recruiting
Phase 1
Hyperpolarized Imaging in Diagnosing Participants With Glioma
Glioma
Susan Chang140 enrolled1 locationNCT03739411
Recruiting
Phase 1
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
High Grade GliomaLow-grade GliomaRecurrent World Health Organization (WHO) Grade II Glioma
University of California, San Francisco50 enrolled17 locationsNCT04485559
Recruiting
Phase 2
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
Thyroid Cancer
Thomas Hope62 enrolled1 locationNCT06961084
Recruiting
Phase 1
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Diffuse Large B-Cell Lymphoma (DLBCL)Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)+6 more
Nurix Therapeutics, Inc.572 enrolled62 locationsNCT05131022
Recruiting
ASSESS ALL ALS Study
Amyotrophic Lateral Sclerosis
St. Joseph's Hospital and Medical Center, Phoenix2,000 enrolled32 locationsNCT06578195
Recruiting
Not Applicable
Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
Nasopharyngeal CancerNasopharyngeal CarcinomaStage III Nasopharyngeal Carcinoma AJCC v8+2 more
University of California, San Francisco66 enrolled1 locationNCT06682442
Recruiting
PREVENT ALL ALS Study
Amyotrophic Lateral Sclerosis
St. Joseph's Hospital and Medical Center, Phoenix600 enrolled32 locationsNCT06581861
Recruiting
Phase 1Phase 2
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Refractory NeuroblastomaRefractory RhabdomyosarcomaRefractory Solid Tumors+3 more
Theodore Laetsch59 enrolled7 locationsNCT06721689
Recruiting
Phase 2
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Madrigal Pharmaceuticals, Inc.120 enrolled17 locationsNCT07335601
Recruiting
Phase 2
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
BRAF V600 MutationLow-grade GliomaLow Grade Glioma of Brain+1 more
University of California, San Francisco96 enrolled7 locationsNCT07110246
Recruiting
Phase 3
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Metastatic CancerAdvanced Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.482 enrolled126 locationsNCT05208047
Recruiting
Phase 1
Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
Multiple MyelomaPlasma Cell Myeloma
Robert Flavell, MD, PhD20 enrolled1 locationNCT05892393
Recruiting
Phase 2
Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
Posterior Fossa Ependymal Tumor
University of California, San Francisco30 enrolled3 locationsNCT07226453
Recruiting
Not Applicable
CONNECTing to LungCare
Lung CarcinomaSmoking CessationCigarette Smoking-Related Carcinoma
University of California, San Francisco152 enrolled1 locationNCT06213532
Recruiting
Smart Discharges for Older Children
Sepsis
University of British Columbia4,000 enrolled7 locationsNCT07629154
Recruiting
Phase 2Phase 3
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Glioblastoma
Global Coalition for Adaptive Research2,250 enrolled63 locationsNCT03970447
Recruiting
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Parkinson DiseaseDystoniaEssential Tremor
Boston Scientific Corporation5,000 enrolled19 locationsNCT03664609